MERTK retinopathy: biomarkers assessing vision loss.

Dhimas Hari Sakti Elisa Eleanor CornishNina MustaficAfsah ZaheerStephanie RetsasSulekha RajagopalanClara Wt ChungLisa EwansPeter J McCluskeyBenjamin M NashRobyn V Jamieson John R B Grigg

Published in: Ophthalmic genetics (2021)

This cohort showed early visual loss, moderately rapid EZ reduction and macular hyperAF. EZ, CMT, and BCVA were consistently reduced. Relative rapid decline in these biomarkers reflecting visual function suggests an early and narrow timespan for intervention.

Keyphrases

randomized controlled trial
loop mediated isothermal amplification
optical coherence tomography
diabetic retinopathy
quantum dots